workflow:
  id: workflow_057_004
  title: Healthcare Genomics Research Investment Workflow
  department: Research & Development
  complexity: high
  participants:
  - Research Directors
  - Genomics Scientists
  - Financial Analysts
  - Regulatory Specialists
  - Clinical Partners
  trigger: Identification of promising genomics research opportunity requiring investment
    evaluation
  steps:
  - step: 1
    actor: Research Directors
    action: Evaluate scientific merit and clinical potential of genomics research
    tools:
    - Scientific literature databases
    - Expert consultation networks
    duration: 2 weeks
    outputs:
    - Scientific evaluation report
    - Clinical potential assessment
  - step: 2
    actor: Genomics Scientists
    action: Assess technical feasibility and timeline for research objectives
    tools:
    - Genomics research platforms
    - Technology assessment tools
    duration: 3 weeks
    outputs:
    - Technical feasibility study
    - Research timeline
    decision_points:
    - Technology maturity
    - Resource requirements
  - step: 3
    actor: Financial Analysts
    action: Conduct comprehensive investment analysis and ROI projections
    tools:
    - Financial modeling software
    - Market analysis tools
    duration: 4 weeks
    outputs:
    - Investment analysis
    - ROI projections
  - step: 4
    actor: Regulatory Specialists
    action: Evaluate regulatory landscape and approval pathways
    tools:
    - Regulatory databases
    - Compliance assessment tools
    duration: 2 weeks
    outputs:
    - Regulatory assessment
    - Approval pathway recommendations
  - step: 5
    actor: Clinical Partners
    action: Assess clinical adoption potential and partnership opportunities
    tools:
    - Clinical trial databases
    - Partnership evaluation frameworks
    duration: 3 weeks
    outputs:
    - Clinical adoption assessment
    - Partnership opportunities
  success_criteria: Research investment approved with clear path to clinical translation
    and market impact
  failure_modes:
  - Insufficient scientific merit
  - Poor ROI projections
  - Regulatory barriers
  - Clinical adoption challenges
